Bei Akademie registrieren
Boston Scientific, US1011371077

Boston Scientific names Fitzgerald COO. Boston Scientific stock costs EUR 39.39 in weekend trading

Published on 10/18/2026 at 17:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Boston Scientific names Joseph M. Fitzgerald COO effective January 1, 2027. Boston Scientific stock costs EUR 39.39 in weekend trading on October 18, 2026.

Leadership and trading points

  • Boston Scientific announced Joseph M. Fitzgerald’s COO appointment on October 7, 2026.
  • Boston Scientific stock trades in weekend trading at Lang & Schwarz at EUR 39.39 at 5:13 p.m. CEST on October 18, 2026.
  • The next Xetra session is scheduled for October 19, 2026.
Architektonisches 3D-Render eines geschwungenen Glas-Bürohochhauses mit Wasserspiegelanlage
Boston Properties US1011371077 präsentiert ein zeitgenössisches Architektur-Render eines Hochhauses mit urbanem Wasserspiegelplatz, Illustration mit AI erstellt.

Boston Scientific Corporation announced on October 7, 2026, that Joseph M. Fitzgerald will become executive vice president and chief operating officer effective January 1, 2027, according to the company’s press release. Boston Scientific stock trades in weekend trading at Lang & Schwarz at EUR 39.39 at 5:13 p.m. CEST on October 18, 2026.

Weekend trading

The company’s announcement said Fitzgerald will oversee Boston Scientific’s global operations, business units and regions. The company also plans to establish three reportable segments effective January 1, 2027: Interventional Therapies, Rhythm Solutions and MedSurg, the company release said.

The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Boston Scientific stock.

Market context: Market report S&P 500.

Leadership transition

A filing with the U.S. Securities and Exchange Commission identified Boston Scientific Corporation as the issuer and stated that Fitzgerald, then executive vice president and group president of Cardiovascular, would become chief operating officer on January 1, 2027. The filing also said Emily Woodworth would leave the chief accounting officer role and Mark Bickel would become chief accounting officer, both effective March 1, 2027. The filing is available from the U.S. Securities and Exchange Commission.

Next Xetra session

The next Xetra session is scheduled for October 19, 2026. No price direction is inferred from the company announcement.

Disclaimer...
en | US1011371077 | BOSTON SCIENTIFIC | boerse | 70354338 | bgmi